- Home
- JFBR vs QLGN Comparison
JFBR vs QLGN Comparison
Compare JFBR & QLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JFBR
- QLGN
- Stock Information
- Founded
- JFBR 2017
- QLGN 1996
- Country
- JFBR Israel
- QLGN United States
- Employees
- JFBR N/A
- QLGN N/A
- Industry
- JFBR Other Specialty Stores
- QLGN Biotechnology: Pharmaceutical Preparations
- Sector
- JFBR Consumer Discretionary
- QLGN Health Care
- Exchange
- JFBR Nasdaq
- QLGN Nasdaq
- Market Cap
- JFBR 3.6M
- QLGN 3.1M
- IPO Year
- JFBR 2022
- QLGN N/A
- Fundamental
- Price
- JFBR $5.52
- QLGN $1.86
- Analyst Decision
- JFBR
- QLGN
- Analyst Count
- JFBR 0
- QLGN 0
- Target Price
- JFBR N/A
- QLGN N/A
- AVG Volume (30 Days)
- JFBR 66.7K
- QLGN 93.1K
- Earning Date
- JFBR 09-30-2025
- QLGN 08-14-2025
- Dividend Yield
- JFBR N/A
- QLGN N/A
- EPS Growth
- JFBR N/A
- QLGN N/A
- EPS
- JFBR N/A
- QLGN N/A
- Revenue
- JFBR $13,688,000.00
- QLGN N/A
- Revenue This Year
- JFBR N/A
- QLGN N/A
- Revenue Next Year
- JFBR N/A
- QLGN N/A
- P/E Ratio
- JFBR N/A
- QLGN N/A
- Revenue Growth
- JFBR 36.77
- QLGN N/A
- 52 Week Low
- JFBR $4.60
- QLGN $1.61
- 52 Week High
- JFBR $101.33
- QLGN $10.84
- Technical
- Relative Strength Index (RSI)
- JFBR 40.95
- QLGN 32.69
- Support Level
- JFBR $5.98
- QLGN $1.82
- Resistance Level
- JFBR $5.81
- QLGN $2.09
- Average True Range (ATR)
- JFBR 0.58
- QLGN 0.14
- MACD
- JFBR -0.08
- QLGN 0.05
- Stochastic Oscillator
- JFBR 16.40
- QLGN 52.08
About JFBR Jeffs' Brands Ltd
Jeffs Brands Ltd is an e-commerce CPG company, operating on Amazon. The company serves as the holding company of other e-commerce companies, Smart Repair Pro, Purex, and Top Rank, that operate online stores for the sale of various consumer products on Amazon online marketplace, utilizing the FBA model. The company has five wholly-owned subsidiaries: Smart Repair Pro, Purex, Top Rank, Fort and Jeffs' Brands Holdings. The company also utilizes internal methodologies to analyze sales data and patterns on Amazon to identify existing stores, niches, and products that have the potential for development and growth, and for maximizing sales of existing proprietary products.
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.